Artivion, Inc. (AORT) is a publicly traded Healthcare sector company. As of October 28, 2026, AORT trades at $22.99 with a market cap of $1.12B and a P/E ratio of -438.40. AORT moved +0.57% today. Year to date, AORT is -48.45%; over the trailing twelve months it is -49.36%. Its 52-week range spans $19.16 to $48.25. Analyst consensus is strong buy with an average price target of $40.31. Rallies surfaces AORT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
7 analysts cover AORT: 0 strong buy, 7 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $40.31.
| Metric | Value |
|---|---|
| Price | $22.99 |
| Market Cap | $1.12B |
| P/E Ratio | -438.40 |
| EPS | $-0.05 |
| Dividend Yield | 0.03% |
| 52-Week High | $48.25 |
| 52-Week Low | $19.16 |
| Volume | 317.12K |
| Avg Volume | 0 |
| Revenue (TTM) | $471.47M |
| Net Income | $-3.17M |
| Gross Margin | 64.37% |
7 analysts cover AORT: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.31.